[go: up one dir, main page]

ES2110411T3 - Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t. - Google Patents

Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t.

Info

Publication number
ES2110411T3
ES2110411T3 ES90309120T ES90309120T ES2110411T3 ES 2110411 T3 ES2110411 T3 ES 2110411T3 ES 90309120 T ES90309120 T ES 90309120T ES 90309120 T ES90309120 T ES 90309120T ES 2110411 T3 ES2110411 T3 ES 2110411T3
Authority
ES
Spain
Prior art keywords
hcv
cultivating
lymphocytes
hepatitis
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90309120T
Other languages
English (en)
Inventor
Amy J Weiner
Kathelyn S Steimer
Michael Houghton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23576300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2110411(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ES2110411T3 publication Critical patent/ES2110411T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Details Of Audible-Bandwidth Transducers (AREA)
  • Telephone Function (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A CELULAS QUE PUEDEN SER UTILIZADAS PARA PROPAGAR HCV EN UN CULTIVO. TAMBIEN SE DIRIGE A LOS ANTIGENOS VIRICOS PRODUCIDOS POR TALES CULTIVOS, Y EL USO DE TALES ANTIGENOS, POR EJEMPLO, EN DIAGNOSIS.
ES90309120T 1989-08-25 1990-08-21 Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t. Expired - Lifetime ES2110411T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39866789A 1989-08-25 1989-08-25

Publications (1)

Publication Number Publication Date
ES2110411T3 true ES2110411T3 (es) 1998-02-16

Family

ID=23576300

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90309120T Expired - Lifetime ES2110411T3 (es) 1989-08-25 1990-08-21 Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t.

Country Status (12)

Country Link
EP (1) EP0414475B1 (es)
JP (3) JPH05502156A (es)
AT (1) ATE161041T1 (es)
AU (1) AU655156B2 (es)
CA (1) CA2064705C (es)
DE (1) DE69031791T2 (es)
DK (1) DK0414475T3 (es)
ES (1) ES2110411T3 (es)
GR (1) GR3026114T3 (es)
IE (1) IE903097A1 (es)
PT (1) PT95093B (es)
WO (1) WO1991002820A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4040339C2 (de) 1989-12-18 1999-07-08 Wellcome Found Virales Agens
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
WO1991015574A1 (en) * 1990-04-03 1991-10-17 Southwest Foundation For Biomedical Research Purified hcv and hcv proteins and peptides
AU7679491A (en) * 1990-04-04 1991-10-30 Protos, Inc. Hepatitis c virus protease inhibitors
US5443965A (en) * 1990-04-06 1995-08-22 Genelabs Incorporated Hepatitis C virus epitopes
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
EP0516270A3 (en) * 1991-04-10 1993-06-23 Immuno Japan Inc. Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides
US5428145A (en) * 1991-08-09 1995-06-27 Immuno Japan, Inc. Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
ES2065863T3 (es) 1991-11-21 2003-09-01 Common Services Agency Analisis para la deteccion de virus de la hepatitis c.
US5552310A (en) * 1992-06-12 1996-09-03 Hiroshi Yoshikura Replication of hepatitis C virus genome and identification of virus having high infectivity
WO1994025064A1 (en) * 1993-05-04 1994-11-10 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMANSERVIC ES Hepatitis c virus cell propagation and related methods
US5840565A (en) * 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5851758A (en) * 1995-10-25 1998-12-22 Childrens Research Institute Cytopathic replication of hepatitis C virus in a new cell line
US6242187B1 (en) 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
DE69711584T2 (de) * 1996-01-29 2002-11-07 Virologic, Inc. Verfahren und zusammensetzungen zur bestimmung der empfindlichkeit und resistenz gegen antivirale wirkstoffe und screening für antivirale wirkstoffe
ATE423204T1 (de) 1996-11-08 2009-03-15 Us Gov Health & Human Serv Herstellung und reinigung von hepatitis c virus- ähnlichen partikeln
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
AT407256B (de) * 1998-06-24 2001-02-26 Immuno Ag Hepatitis c-virus positive endometriale zelllinie
EP1947185B1 (en) 2000-08-17 2011-07-20 Tripep Ab HCV NS3/4A encoding nucleic acid
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
EP1888751A2 (en) 2005-05-25 2008-02-20 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
EP2185195A2 (en) 2007-08-16 2010-05-19 Tripep Ab Immunogen platform
US20090214593A1 (en) 2007-08-16 2009-08-27 Tripep Ab Immunogen platform
GB201119011D0 (en) * 2011-11-03 2011-12-14 Queen Mary Innovation Ltd Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
CA1168579A (en) * 1981-02-11 1984-06-05 Philippe Maupas (Deceased) Non-a, non-b hepatitis virus
JPS63502962A (ja) * 1986-04-01 1988-11-02 ジーンラブズ　インコーポレイテッド ウイルス特異的な永久増殖性組織細胞
ES2012739T5 (es) * 1987-11-18 2001-12-01 Chiron Corp Diagnosticos para nanbv.

Also Published As

Publication number Publication date
AU655156B2 (en) 1994-12-08
EP0414475A1 (en) 1991-02-27
WO1991002820A1 (en) 1991-03-07
ATE161041T1 (de) 1997-12-15
EP0414475B1 (en) 1997-12-10
PT95093A (pt) 1991-05-22
DE69031791D1 (de) 1998-01-22
JP2004049235A (ja) 2004-02-19
AU6344990A (en) 1991-04-03
GR3026114T3 (en) 1998-05-29
JP2001314192A (ja) 2001-11-13
CA2064705C (en) 1999-04-06
DK0414475T3 (da) 1998-02-09
JPH05502156A (ja) 1993-04-22
IE903097A1 (en) 1991-02-27
CA2064705A1 (en) 1991-02-26
PT95093B (pt) 1997-11-28
DE69031791T2 (de) 1998-04-02

Similar Documents

Publication Publication Date Title
ES2110411T3 (es) Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t.
EA199800272A1 (ru) Фактор, стимулирующий дендритные клетки
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
ATE364621T1 (de) Hiv-peptide
ES2189185T3 (es) Reactivos para vacunacion capaces de generar una respuesta inmunitaria de las celulas t cd8.
ES2061500T5 (es) Diagnosis y vacunas de la hepatitis delta, su preparacion y uso.
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
FI935808A0 (fi) Hepatit-C-virus (HCV) polypeptider
ES2054696T3 (es) Agente viral de la hepatitis nanb, antigen y reactivo inmunologico.
ES2138784T3 (es) Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
ES2067528T3 (es) Lineas celulares continuas en la produccion de vbi.
CA2098021A1 (en) Composition Used as a Therapeutic Agent Against Chronic Viral Hepatic Diseases
ES8404186A1 (es) "un procedimiento para obtener al menos un polipeptido que presenta la antigenicidad de los antigenos e del virus de la hepatitis b".
DK372780A (da) Fremgangsmaade til propagering af humant hepatitis a virus
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
NO800724L (no) Fremgangsmaate til fremstilling peptider med ubiquitinlignende aktivitet
ES2061603T3 (es) Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos.
ES2058259T3 (es) Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
FI923020A0 (fi) Inte a inte b-sekvenser.
JPS53104687A (en) Preparation of propylene-ethylene elastic copolymer
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
JPS52151114A (en) Preparation of dimethylforamide
Centers for Disease Control (CDC Anonymous survey for simian immunodeficiency virus (SIV) seropositivity in SIV-laboratory researchers--United States, 1992
DE59100308D1 (de) Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren.
JPS6470577A (en) Modified polybutene-based hot-melt composition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 414475

Country of ref document: ES